Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06299137 · ClinicalTrials.gov registry record · Early Phase 1
Ultrasound Guided Serratus Anterior Plane Block in ED Patients With Rib Fractures
A Early Phase 1 study of Opioid Use and Pain, Acute, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06299137 is a Early Phase 1 study of Opioid Use and Pain, Acute that has completed, run by Rhode Island Hospital. The registered enrollment target is 40 participants, below the 148,260-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06299137, a Early Phase 1 study of Opioid Use and Pain, Acute, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test the effectiveness of the Serratus Anterior Plane Block in patients with rib fractures. The main questions it aims to answer are: * Determine if UG-SAPB results in an improved pain, incentive spirometry, and cough ability (PIC) score when compared to usual care over the first five hours. * Evaluate if UG-SAPB results in fewer opioid medications administered when compared to usual care over the first 24 hours. Participants will undergo the Serratus Anterior Plane. Researchers will compare this to usual care to see if this intervention improves pulmonary function and reduces opioid requirements for ED patients with rib fractures.
Conditions Studied
Interventions
- DRUG Ropivacaine injection
- PROCEDURE Serratus Anterior Plane Block
Study Locations (1)
Rhode Island
- Rhode Island Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2025-12-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06299137
The ClinicalTrials.gov registry entry for NCT06299137 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,260-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Opioid Use appearing as the primary indexed condition, and to 2 interventions - of which Ropivacaine injection is the first listed.
NCT06299137 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.
Frequently Asked Questions
What is clinical trial NCT06299137 about?
NCT06299137 is a clinical study titled "Ultrasound Guided Serratus Anterior Plane Block in ED Patients With Rib Fractures". The goal of this clinical trial is to test the effectiveness of the Serratus Anterior Plane Block in patients with rib fractures. The main questions it aims to answer are: * Determine if UG-SAPB results in an improved pain, incentive spirometry, and cough ability (PIC) score when compared to usual ...
What is the current status of trial NCT06299137?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2024-07-01. Estimated completion is 2025-12-01.
What conditions does trial NCT06299137 study?
This clinical trial studies the following conditions: Opioid Use, Pain, Acute, Rib Fractures, Regional Anesthesia.
What interventions are being tested in trial NCT06299137?
The interventions under investigation include: Ropivacaine injection (DRUG), Serratus Anterior Plane Block (PROCEDURE).
Who is sponsoring clinical trial NCT06299137?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06299137 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Neuroinflammation FNOS PET/CT in HIV (+) and (-) Subjects With OUD and Healthy Controls
ACTIVE NOT RECRUITING · Early Phase 1
-
Enhancing Prospective Thinking in Early Recovery (PARK)
COMPLETED · Early Phase 1
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
RECRUITING · Phase 3
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.